However, CSS treatment alleviated the RS-induced colitis: it inhibited colon shortening, suppressed myeloperoxidase activity and NF-κB activation (p-p65 to p65 ratio), and decreased IL-6 expression. This evidence concerns the gene NFKB1 and colitis.